Day: May 7, 2020

Ovaro Kiinteistösijoitus OyjOsavuosikatsaus 1.1.-31.3.2020Pörssitiedote 7.5.2020 klo 8.30YHTEENVETO KAUDELTA 1-3/2020 (VERTAILUKAUSI 1-3/2019)Koronaviruspandemia levisi Suomeen maaliskuun aikana. Pandemian aiheuttama taloudellinen epävarmuus ei vaikuttanut Ovaron toimintaan ensimmäisellä kvartaalilla, mutta siitä johtuvalla epävarmuudella voi olla vaikutuksia loppuvuoden liiketoimintaan.  Pandemian arvioidaan vaikuttavan asuntojen myyntimäärään, joka voi laskea Ovaron tulevaa kassavirtaa. Vuokrausasteen kehittymiseen Koronapandemian vaikutusten arvioidaan olevan vähäisempiä. Pandemiasta huolimatta Ovaro kehittää vuokrausliiketoimintaansa aktiivisilla toimenpiteillä.  Taloudellisen epävarmuuden myötä Ovaron vuokralaisille voi aiheutua maksuvaikeuksia lomautuksien ja työttömyyden seurauksena.Koronapandemian vuoksi yhtiön tulevaisuuden näkymiä...

Heijmans has been selected by housing corporation Woonbedrijf as a partner for the Humperdincklaan area development plan in Eindhoven. The project comprises the development and realization of some five hundred rental and owner-occupied homes, valued at over €100 million.The project will provide a stimulus to the Gestel district, creating extra affordable housing for a range of target groups. Heijmans was selected because of its extensive knowledge and experience in area development and district restructuring. This has enabled Woonbedrijf to bring the knowledge of infrastructure, development and construction of the project under one umbrella. Heijmans’ proposal for the deployment of these disciplines and the project’s cooperation method received positive approval. Both parties will jointly work out the project plans over the coming months.The...

Heijmans is door woningcorporatie Woonbedrijf geselecteerd als partner voor het plan gebiedsontwikkeling Humperdincklaan in Eindhoven. Het project omvat het ontwikkelen en realiseren van circa vijfhonderd huur- en koopwoningen en heeft een waarde van ruim € 100 miljoen.Met het project wordt een impuls gegeven aan het stadsdeel Gestel en extra betaalbare woonruimte gecreëerd voor uiteenlopende doelgroepen. Heijmans is geselecteerd vanwege de uitvoerige kennis en ervaring die het bedrijf heeft met gebiedsontwikkeling en herstructurering van wijken. Hiermee heeft Woonbedrijf de kennis op het gebied van infrastructuur, ontwikkeling en bouwen onder één paraplu aan het project verbonden. Het voorstel van Heijmans voor de inzet van deze disciplines en de wijze van samenwerking in het project, is positief ontvangen. De komende maanden werken...

7 May 2020

7 Mai 2020

Press release, Paris, France 7th May 2020Q1 2020 FINANCIAL INFORMATIONStable Group sales in unprecedented crisisTransformation program reinforced and implemented group-widePaving the way for a stronger NexansStandard sales of 1,569 million euros in the first-quarter 2020, representing organic growth of -0.1% year-on-yearStrong backlog in Subsea (1.6 billion euros1) with no delays in project executionChina back to full operations, Europe and North America impacted by partial lockdownsStrong actions to cope with the sanitary crisis and to preserve liquidity:Increased cost reduction targets and strict cash managementProposed cancelation of dividend payment to shareholdersReduced fixed compensation by 30% reduction for the Board of Directors and CEO, and by 15% for Executive Committee280 million euros loan guaranteed by the French State,...

Communiqué de Presse, Paris, France 7 Mai 2020INFORMATIONS FINANCIÈRES DU T1 2020Chiffre d’affaires stable sur fond de crise sans précédentProgramme de transformation renforcé et déployé dans l’ensemble du GroupeBâtir un Nexans plus solideChiffre d’affaires du premier trimestre 2020 de 1 569 millions d’euros à cours des métaux constant, en croissance organique de -0,1 % en base comparableSolide carnet de commandes de l’activité sous-marine (1,6 milliards d’euros1) sans retard dans l’exécution des projetsL’activité a pleinement repris en Chine, tandis qu’elle reste affectée par le confinement partiel en Europe et en Amérique du NordMesures fortes pour faire face à la crise sanitaire et préserver la liquidité :Objectifs de réduction de coûts renforcés et gestion rigoureuse de la trésorerieProposition de ne pas verser les dividendes aux...

NEW YORK, N.Y., and TEL AVIV, Israel, May 07, 2020 (GLOBE NEWSWIRE) — BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, announced today a lease agreement with the Tel Aviv Sourasky Medical Center (“Sourasky) in Tel Aviv, Israel, to produce NurOwn® in three state-of-the-art cleanrooms. The new facility will significantly increase the Company’s capacity to manufacture and ship its product into the European Union and the local Israeli market. The cleanroom facility is part of Sourasky’s Institute for Advanced Cellular Therapies.“Sourasky Hospital is a leader in the advancement and manufacturing of cell and gene therapy products and is well-equipped to rapidly scale up and produce NurOwn,” stated Prof. Ronni Gamzu, CEO of Tel Aviv Sourasky Medical...

MONT-SAINT-GUIBERT, Belgium, May 07, 2020 (GLOBE NEWSWIRE) — Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T cell therapies, today announced an update on operational developments for the first quarter ended March 31, 2020.“I am extremely proud of our team’s dedication and focus over the past few months in progressing the development of our exciting CAR-T therapies during the COVID-19 pandemic. As a result of their efforts, we’ve continued to advance our programs, bringing us closer to several key milestones associated with our clinical and preclinical programs over the course of 2020. Specifically, we anticipate announcing additional data from our CYAD-101 alloSHRINK Phase 1 trial at ASCO, and filing the IND application for our lead shRNA-based...

 Limited business impact of COVID-19 crisis during Q1Unprecedented partnering deal signed for Phase 2 Lyme vaccine candidate2020 full-year financial guidance updated with improved EBITDASARS-CoV-2 vaccine development program for COVID-19 initiatedSolid financial results in Q1 2020, with limited COVID-19 impactProduct sales revenue of €32.7 million in Q1 2020, similar to Q1 2019 (€32.8 million)Total revenues of €35.2 million in Q1 2020, similar to Q1 2019 (€34.9 million)Gross margin on product sales revenues of 69.4% in Q1 2020 driven by geographical mix and strong operational performance in manufacturingEBITDA1 of €2.4 million in Q1 2020, lower than Q1 2019 (€8.2 million) due to increased R&D investmentsPositive operating cash flow of €3.0 million in Q1 2020Strong cash position of €80.8 million at the end of March 2020Supported by...